198 related articles for article (PubMed ID: 24064977)
1. Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen.
Reginato E; Mroz P; Chung H; Kawakubo M; Wolf P; Hamblin MR
Br J Cancer; 2013 Oct; 109(8):2167-74. PubMed ID: 24064977
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model.
Castano AP; Mroz P; Wu MX; Hamblin MR
Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5495-500. PubMed ID: 18378905
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response.
Mroz P; Szokalska A; Wu MX; Hamblin MR
PLoS One; 2010 Dec; 5(12):e15194. PubMed ID: 21179470
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
[TBL] [Abstract][Full Text] [Related]
5. 5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.
Wachowska M; Gabrysiak M; Muchowicz A; Bednarek W; Barankiewicz J; Rygiel T; Boon L; Mroz P; Hamblin MR; Golab J
Eur J Cancer; 2014 May; 50(7):1370-81. PubMed ID: 24559534
[TBL] [Abstract][Full Text] [Related]
6. Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12.
Malvicini M; Ingolotti M; Piccioni F; Garcia M; Bayo J; Atorrasagasti C; Alaniz L; Aquino JB; Espinoza JA; Gidekel M; Scharovsky OG; Matar P; Mazzolini G
Mol Oncol; 2011 Jun; 5(3):242-55. PubMed ID: 21515097
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity.
Saxton ML; Longo DL; Wetzel HE; Tribble H; Alvord WG; Kwak LW; Leonard AS; Ullmann CD; Curti BD; Ochoa AC
Blood; 1997 Apr; 89(7):2529-36. PubMed ID: 9116299
[TBL] [Abstract][Full Text] [Related]
8. Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimens.
Rocha LB; Gomes-da-Silva LC; Dąbrowski JM; Arnaut LG
Eur J Cancer; 2015 Sep; 51(13):1822-30. PubMed ID: 26139544
[TBL] [Abstract][Full Text] [Related]
9. Anamnestic responses induced by antigen persisting on follicular dendritic cells from cyclophosphamide-treated mice.
Phipps RP; Mandel TE; Schnizlein CT; Tew JG
Immunology; 1984 Feb; 51(2):387-97. PubMed ID: 6607214
[TBL] [Abstract][Full Text] [Related]
10. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
Saji H; Song W; Furumoto K; Kato H; Engleman EG
Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867
[TBL] [Abstract][Full Text] [Related]
11. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy.
Castano AP; Liu Q; Hamblin MR
Br J Cancer; 2006 Feb; 94(3):391-7. PubMed ID: 16421588
[TBL] [Abstract][Full Text] [Related]
12. Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.
Manrique SZ; Dominguez AL; Mirza N; Spencer CD; Bradley JM; Finke JH; Lee JJ; Pease LR; Gendler SJ; Cohen PA
Oncotarget; 2016 Jul; 7(28):42919-42942. PubMed ID: 27341020
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF.
Gołab J; Wilczyński G; Zagozdzon R; Stokłosa T; Dabrowska A; Rybczyńska J; Wasik M; Machaj E; Ołda T; Kozar K; Kamiński R; Giermasz A; Czajka A; Lasek W; Feleszko W; Jakóbisiak M
Br J Cancer; 2000 Apr; 82(8):1485-91. PubMed ID: 10780531
[TBL] [Abstract][Full Text] [Related]
14. Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.
Zhao J; Cao Y; Lei Z; Yang Z; Zhang B; Huang B
Cancer Res; 2010 Jun; 70(12):4850-8. PubMed ID: 20501849
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden.
Awwad M; North RJ
Immunology; 1988 Sep; 65(1):87-92. PubMed ID: 2972604
[TBL] [Abstract][Full Text] [Related]
16. Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer.
Zhang D; Xie Q; Liu Y; Li Z; Li H; Li S; Li Z; Cui J; Su M; Jiang X; Xue P; Bai M
Pharmacol Res; 2021 Oct; 172():105811. PubMed ID: 34390852
[TBL] [Abstract][Full Text] [Related]
17. Translating phototherapeutic indices from in vitro to in vivo photodynamic therapy with bacteriochlorins.
Luz AFS; Pucelik B; Pereira MM; Dąbrowski JM; Arnaut LG
Lasers Surg Med; 2018 Jul; 50(5):451-459. PubMed ID: 29714399
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.
Kabingu E; Vaughan L; Owczarczak B; Ramsey KD; Gollnick SO
Br J Cancer; 2007 Jun; 96(12):1839-48. PubMed ID: 17505510
[TBL] [Abstract][Full Text] [Related]
20. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma.
Sanovic R; Verwanger T; Hartl A; Krammer B
Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):291-6. PubMed ID: 22122915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]